Pfeiffenberger, J., Koschny, R., Hoffmann, K., Mehrabi, A., Schmitz, A., Radeleff, B., . . . Ganten, T. M. (2013). Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation. Langenbeck's archives of surgery, 398(8), . https://doi.org/10.1007/s00423-013-1114-1
Chicago-Zitierstil (17. Ausg.)Pfeiffenberger, Jan, Ronald Koschny, Katrin Hoffmann, Arianeb Mehrabi, Anne Schmitz, Boris Radeleff, Wolfgang Stremmel, Peter Schemmer, und Tom M. Ganten. "Sorafenib Treatment Is Save and May Affect Survival of Recurrent Hepatocellular Carcinoma After Liver Transplantation." Langenbeck's Archives of Surgery 398, no. 8 (2013). https://doi.org/10.1007/s00423-013-1114-1.
MLA-Zitierstil (9. Ausg.)Pfeiffenberger, Jan, et al. "Sorafenib Treatment Is Save and May Affect Survival of Recurrent Hepatocellular Carcinoma After Liver Transplantation." Langenbeck's Archives of Surgery, vol. 398, no. 8, 2013, https://doi.org/10.1007/s00423-013-1114-1.